8-K: Body and Mind Inc. Reports Modest Revenue Growth and Improved Bottom Line in Q3 2024

Body and Mind Inc. announced its Q3 2024 financial results, showing modest revenue growth and improvements in net loss compared to the same period last year.

Summary

• Body and Mind Inc. (BaM) released its financial results for the third quarter of fiscal year 2024, which ended on April 30, 2024.
• The company reported revenue of $4.41 million for the quarter, compared to $4.17 million in the same quarter of the previous year.
• Gross profit for the quarter was $1.96 million, slightly up from $1.92 million in Q3 2023.
• The net loss for the quarter was $2.54 million, an improvement from the $3.61 million loss in the same quarter last year.
• For the nine-month period ending April 30, 2024, revenue was $13.39 million, compared to $13.24 million in the same period of the previous year.
• The net loss for the nine-month period was $2.54 million, a significant improvement from the $9.30 million loss in the same period last year.
• The company continues to develop its dispensaries in Illinois and New Jersey.
• The Lynwood, Illinois dispensary construction is complete, with final roadwork and service connections pending.
• The New Jersey dispensary in Lawrenceville has received its annual license and building permit, with demolition complete.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to improved financial results and progress in dispensary development, although the company is still operating at a loss and has experienced some delays.

Positives

• Revenue increased in both the three-month and nine-month periods compared to the previous year.
• The company's net loss has significantly decreased for both the three-month and nine-month periods.
• The Markham, Illinois dispensary is showing positive growth trends.
• The Lynwood, Illinois dispensary construction is complete and awaiting final roadwork.
• The New Jersey dispensary has received its annual license and building permit.
• The New Jersey dispensary is located in a prime location with high traffic.

Negatives

• The company continues to operate at a net loss, although it has improved.
• The Lynwood, Illinois dispensary opening was delayed due to a permit issue with the Illinois Department of Transportation.

Risks

• The company is still operating at a loss, indicating potential financial challenges.
• Delays in obtaining permits and completing construction could impact the company's timeline and revenue projections.
• The cannabis industry is subject to regulatory changes and market fluctuations, which could affect the company's performance.

Future Outlook

The company believes the Illinois and New Jersey markets remain underserved and that their strong locations and capabilities will support high returning operations for the company and shareholders. They are focused on completing construction of the Lynwood, Illinois dispensary.

Management Comments

• We continue to execute on our strategy of reducing our footprint and focusing on developing our most valuable assets, stated Michael Mills, CEO of Body and Mind.
• Our quarterly and nine-month financial results demonstrate modest revenue growth and improvements in bottom line results as we continue to streamline our operations.
• We're pleased that our Lynwood, Illinois location has recently received approval to connect the completed building to services and commence required roadwork.
• We look forward to completing construction for this operation shortly.
• We believe the Illinois and New Jersey markets remain underserved and our strong locations and capabilities will support high returning operations for the Company and shareholders.

Industry Context

The announcement reflects the ongoing expansion and development within the cannabis industry, particularly in states like Illinois and New Jersey, where new dispensaries are being established to meet growing demand. The focus on operational efficiency and strategic location is a common theme among cannabis companies seeking to maximize profitability.

Comparison to Industry Standards

• Comparing Body and Mind's results to other multi-state cannabis operators, the revenue growth is modest but the improvement in net loss is a positive sign.
• Companies like Curaleaf and Green Thumb Industries, which are larger, have reported higher revenues but also significant operating costs.
• Body and Mind's focus on strategic locations in underserved markets is similar to strategies employed by smaller, more focused operators like Jushi Holdings.
• The delay in the Lynwood dispensary highlights the challenges in navigating regulatory hurdles, a common issue in the cannabis industry.
• The New Jersey dispensary's location on a high-traffic corridor is a strategic move similar to other successful dispensaries in the industry.

Stakeholder Impact

• Shareholders may view the improved financial results and progress in dispensary development positively.
• Employees may benefit from the company's growth and expansion.
• Customers in Illinois and New Jersey will have access to new retail locations.
• Suppliers may see increased business opportunities with the company's expansion.

Next Steps

• Complete construction and open the Lynwood, Illinois dispensary.
• Complete construction and open the New Jersey dispensary in Lawrenceville.
• Continue to focus on operational efficiencies and strategic growth.

Key Dates

Keywords

cannabis, dispensary, financial results, revenue, net loss, Illinois, New Jersey, operational update, construction, permits